Article · 13 Feb 2026
Conference abstractPublished 23 Nov 2012
Comparision of disintegrants and super disintegrants activity in oral disintegration tablets
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Orally disintegrating tablets offer an advantage for populations who have difficulty in swallowing (dysphagia), disperse quickly in mouth and shows rapid action. Bioavailability of drugs can be increased by formulating oral-disintegrating tablets which can bypass first pass metabolism and provide a better therapeutic profile than oral route. Dissolution time is important for therapeutic action and it mainly depending upon the characters and percentage of disintegrating agents used. The main objective of this research was to compare the oral disintegrating time and % dissolution of sumatriptan succinate ODTs prepared by using disintegrants (carbopol 940, sodium CMC and sodium alginate) and superdisintegrants (crosspovidone, crosscaramellose and sodium starch glycollate). The tablets are prepared by direct compression method. The formulations was optimized by incorporating varying composition of different superdisintegrants (1.5, 3and 6% conc. each), disintegrants (2%, 4% and 6% conc. each) and combination of superdisintegrants, with other additives. All the excipients are tested for compatability. The preformulation parameters were analyzed for prepared tablet blend before compression. The thickness, hardness, friability, weight variation, disintegration time and drug content uniformity was evaluated for core tablets. The effect of these variables on drug release also studied. Based on the disintegration time, dissolution profiles, F-3 formulation (containing 6% crosspovidone) disintegrates with in 15±0.48 sec., gives 96.96% drug release with in 10min, F-10 formulation (containing 2% carbopol 940) disintegrates with in 24±0.33 sec., gives 94.10% drug release with in 10min and F-20formulation (the combination of cross povidone 6% and cross caramellose 6%) disintegrates with in 10±0.24 sec., gives 98.86% drug release with in 10min. so the crosspovidone at 6% and carbopol 940 at 2% concentration release the drug faster when compared to the other superdisintegrants and disintegrants respectively. But the combination of superdisintegrants will improve the disintegration time as well as drug release than simple disintegrants or superdisintegrants alone.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “T. Vedavathi”
- BylineArticles whose byline prints “Rapolu Bharath Kumar”
